After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Navi Finserv will use the funds to expand and grow its digital personal loan business, leveraging new technological advancements to strengthen its position in India's expanding digital lending sector.

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

Morgan Stanley (NYSE:MS) updated its outlook on Kirin Holdings Co Ltd (2503:JP) (OTC: KNBWY), raising the company's price target from ¥2,200 to ¥2,250, while sustaining an Equalweight rating on the ...

JPMorgan Chase & Co. grew its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) by 49.3% in the ...

Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) fell 3.9% on Friday . The company traded as low as $10.46 and last traded at $10.36. 8,771 shares changed hands during mid-day trading, a ...

K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

The House Oversight Committee is asking "tech leaders who have spoken publicly about debanking to share their stories." ...

Kevin Willsey, a JPMorgan Chase & Co. global chair of investment banking and capital markets, is retiring after more than ...

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

Some of the other senior executives at the bank also saw their compensation rising by between 4% and 21% in 2024.

JPMorgan Chase said Thursday that long-serving CEO Jamie Dimon’s 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking and fundraising ...